Friedman Charlene A

CIK 00014137481 companyMOUNTAIN VIEW, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001413748

Recent Transactions

43 trades

Disposition to Issuer
MAP Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2013-03-01−27,500→ 0 total
Disposition to Issuer
MAP Pharmaceuticals, Inc.
Restricted Stock Unit (RSU)
2013-03-01−8,250→ 0 total
Disposition to Issuer
MAP Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2013-03-01−74,744→ 0 total
Disposition from Tender
MAP Pharmaceuticals, Inc.
Common Stock
2013-03-01$25.00/sh−4,229→ 0 total
Disposition to Issuer
MAP Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2013-03-01−30,000→ 0 total
Disposition to Issuer
MAP Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2013-03-01−50,805→ 0 total
Disposition to Issuer
MAP Pharmaceuticals, Inc.
Restricted Stock Unit (RSU)
2013-03-01−4,500→ 0 total
Disposition to Issuer
MAP Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2013-03-01−32,500→ 0 total
Disposition to Issuer
MAP Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2013-03-01−55,000→ 0 total
Exercise/Conversion
MAP Pharmaceuticals, Inc.
Common Stock
2013-01-26+2,250→ 5,100 total
Exercise/Conversion
MAP Pharmaceuticals, Inc.
Common Stock
2013-01-26−2,250→ 4,500 total
Tax Payment
MAP Pharmaceuticals, Inc.
Common Stock
2013-01-26$24.75/sh−871→ 4,229 total
Tax Payment
MAP Pharmaceuticals, Inc.
Common Stock
2013-01-25$24.75/sh−1,207→ 2,850 total
Exercise/Conversion
MAP Pharmaceuticals, Inc.
Common Stock
2013-01-25+2,750→ 4,057 total
Exercise/Conversion
MAP Pharmaceuticals, Inc.
Common Stock
2013-01-25−2,750→ 8,250 total
Exercise/Conversion
MAP Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2012-03-09−10,000→ 22,328 total
Sale
MAP Pharmaceuticals, Inc.
Common Stock
2012-03-09$17.50/sh−10,000→ 1,307 total
Exercise/Conversion
MAP Pharmaceuticals, Inc.
Common Stock
2012-03-09$12.37/sh+10,000→ 11,307 total
Exercise/Conversion
MAP Pharmaceuticals, Inc.
Restricted Stock Unit (RSU)
2012-01-26−2,250→ 6,750 total
Tax Payment
MAP Pharmaceuticals, Inc.
Common Stock
2012-01-26$13.84/sh−943→ 1,307 total
Exercise/Conversion
MAP Pharmaceuticals, Inc.
Common Stock
2012-01-26+2,250→ 2,250 total
Award
MAP Pharmaceuticals, Inc.
Restricted Stock Unit (RSU)
2012-01-25+11,000→ 11,000 total
Award
MAP Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2012-01-25+32,500→ 32,500 total
Award
MAP Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2011-01-26+27,500→ 27,500 total
Award
MAP Pharmaceuticals, Inc.
Restricted Stock Unit (RSU)
2011-01-26+9,000→ 9,000 total
Exercise/Conversion
MAP Pharmaceuticals, Inc.
Stock Option
2010-12-20−3,120→ 38,828 total
Exercise/Conversion
MAP Pharmaceuticals, Inc.
Common Stock
2010-12-20$10.37/sh+3,120→ 3,120 total
Sale
MAP Pharmaceuticals, Inc.
Common Stock
2010-12-20$15.50/sh−3,120→ 0 total
Exercise/Conversion
MAP Pharmaceuticals, Inc.
Common Stock
2010-10-27$10.37/sh+7,800→ 7,800 total
Exercise/Conversion
MAP Pharmaceuticals, Inc.
Stock Option
2010-10-27−7,800→ 41,948 total
Sale
MAP Pharmaceuticals, Inc.
Common Stock
2010-10-27$15.53/sh−7,800→ 0 total
Exercise/Conversion
MAP Pharmaceuticals, Inc.
Stock Option
2010-05-13−1,560→ 49,748 total
Exercise/Conversion
MAP Pharmaceuticals, Inc.
Common Stock
2010-05-13$10.37/sh+1,560→ 1,560 total
Sale
MAP Pharmaceuticals, Inc.
Common Stock
2010-05-13$17.07/sh−1,560→ 0 total
Sale
MAP Pharmaceuticals, Inc.
Common Stock
2010-04-26$18.03/sh−10,155→ 0 total
Exercise/Conversion
MAP Pharmaceuticals, Inc.
Stock Option
2010-04-26−10,155→ 51,308 total
Exercise/Conversion
MAP Pharmaceuticals, Inc.
Common Stock
2010-04-26$10.37/sh+10,155→ 10,155 total
Exercise/Conversion
MAP Pharmaceuticals, Inc.
Common Stock
2010-04-14$10.37/sh+1,560→ 1,560 total
Exercise/Conversion
MAP Pharmaceuticals, Inc.
Stock Option
2010-04-14−1,560→ 61,463 total
Sale
MAP Pharmaceuticals, Inc.
Common Stock
2010-04-14$16.05/sh−1,560→ 0 total
Award
MAP Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2010-02-02+55,000→ 55,000 total
Award
MAP Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2009-02-11$10.37/sh+75,000→ 75,000 total
Award
MAP Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2008-01-22$13.12/sh+30,000→ 30,000 total

Companies

MAP Pharmaceuticals, Inc.
VP President, Gen Counsel &Sec

Recent Filings

Address

C/O MAP PHARMACEUTICALS, INC. 2400 BAYSHORE PARKWAY, SUITE 200

MOUNTAIN VIEW, CA, 94043

View on SEC.gov